Stephen Xu

2.5k citations

63 papers · 1.9k · h-index 26

Impact in

Rheumatology top 0.5%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
Hematology top 2%
- Autoimmune and Inflammatory Disorders Research

Papers in

Rheumatology 45
- Rheumatoid Arthritis Research and Therapies 24
- Spondyloarthritis Studies and Treatments 23
- Systemic Lupus Erythematosus Research 3
Genetics 4
- Chronic Lymphocytic Leukemia Research 4

Co-authors: Benjamin Hsu (10 shared papers)Désirée van der Heijde (8 shared papers)Jürgen Braun (9 shared papers)Elizabeth C. Hsia (26 shared papers)Robert D. Inman (6 shared papers)Daniel Aletaha (2 shared papers)Josef S Smolen (2 shared papers)E. William St. Clair (2 shared papers)
Journals: Annals of the Rheumatic Diseases (13 papers)Lara D. Veeken (6 papers)Arthritis Care & Research (5 papers)Arthritis Research & Therapy (4 papers)Rheumatology and Therapy (4 papers)
Partner nations: United States Canada Germany

In The Last Decade

Stephen Xu

62 papers receiving 1.8k citations

Peers

Countries citing papers authored by Stephen Xu

Since Specialization

Citations

This map shows the geographic impact of Stephen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Xu more than expected).

Fields of papers citing papers by Stephen Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Xu. The network helps show where Stephen Xu may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephen Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen Xu Line = papers co-authored together Stephen Xu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis Lara D. Veeken ·Nathan Vastesaeger, Stephen Xu, Daniel Aletaha, E. William St. Clair, Josef S Smolen	2009	184
2	Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year Journal of the American Academy of Dermatology ·Phoebe Rich, C.E.M. Griffiths, Kristian Reich, Frank O. Nestlé, Richard K. Scher, Shu Li, Stephen Xu, Ming-Chun Hsu, Cynthia Guzzo	2007	131
3	Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study Annals of the Rheumatic Diseases ·Edward Keystone, Mark C. Genovese, Lars Klareskog, Elizabeth C. Hsia, Stephen Hall, Pedro C. Miranda, J Pazdur, Sang‐Cheol Bae, William Palmer, Stephen Xu, Mahboob U. Rahman	2010	121
4	Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension Annals of the Rheumatic Diseases ·Nicolino Ruperto, D. Lovell, R. Cuttica, Patricia Woo, SM Meiorin, Carine Wouters, Earl D. Silverman, Zsolt J. Balogh, Michael Henrickson, (unknown), Ivan Foeldvari, Lisa F. Imundo, Gabriele Simonini, J Oppermann, Stephen Xu, Yaung‐Kaung Shen, Sudha Visvanathan, Adedigbo A. Fasanmade, (unknown), Alberto Martini, Edward H. Giannini	2010	107
5	Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study Annals of the Rheumatic Diseases ·Atul Deodhar, Jürgen Braun, Robert D. Inman, Désirée van der Heijde, Yiying Zhou, Stephen Xu, Chenglong Han, Benjamin Hsu	2014	103
6	The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial Annals of the Rheumatic Diseases ·Jürgen Braun, Xenofon Baraliakos, Kay‐Geert Hermann, Atul Deodhar, Désirée van der Heijde, Robert D. Inman, Anna Beutler, Yiying Zhou, Stephen Xu, Benjamin Hsu	2013	99
7	Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study Annals of the Rheumatic Diseases ·Jürgen Braun, Atul Deodhar, Robert D. Inman, Désirée van der Heijde, M. Mack, Stephen Xu, Benjamin Hsu	2011	83
8	Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis Inflammatory Bowel Diseases ·Walter Reinisch, William J. Sandborn, Mohan Bala, Songkai Yan, Brian G. Feagan, Paul Rutgeerts, Graham Radford‐Smith, Stephen Xu, D. Eisenberg, Allan Olson, Jean‐Frédéric Colombel	2007	82
9	Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study Annals of the Rheumatic Diseases ·Jürgen Braun, Xenofon Baraliakos, Kay‐Geert Hermann, Désirée van der Heijde, Robert D. Inman, Atul Deodhar, Anna Baratelle, Stephen Xu, Weichun Xu, Benjamin Hsu	2011	74
10	Interferon‐γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti–tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis Arthritis & Rheumatism ·Elizabeth C. Hsia, Neil W. Schluger, John J. Cush, Richard E. Chaisson, Eric L. Matteson, Stephen Xu, Anna Beutler, Mittie K. Doyle, Benjamin Hsu, Mahboob U. Rahman	2012	66
11	Radiographic Progression of Patients With Psoriatic Arthritis Who Achieve Minimal Disease Activity in Response to Golimumab Therapy: Results Through 5 Years of a Randomized, Placebo‐Controlled Study Arthritis Care & Research ·Arthur Kavanaugh, Désirée van der Heijde, Anna Beutler, Dafna D. Gladman, Philip J. Mease, Gerald G. Krueger, Iain B. McInnes, Philip Helliwell, Laura C. Coates, Stephen Xu	2015	64
12	Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing Annals of the Rheumatic Diseases ·Josef S Smolen, Désirée van der Heijde, Daniel Aletaha, Stephen Xu, John Han, Daniel L. Baker, E. William St. Clair	2008	55
13	Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti–tumor necrosis factor antibody, in Phase III clinical trials Arthritis Care & Research ·Elizabeth C. Hsia, John J. Cush, Eric L. Matteson, Anna Beutler, Mittie K. Doyle, Benjamin Hsu, Stephen Xu, Mahboob U. Rahman	2012	50
14	Positive treatment effects of ustekinumab in psoriasis: Analysis of lesional and systemic parameters The Journal of Dermatology ·Manjula Reddy, Gisela Torres, Thomas S. McCormick, Colleen Marano, Kevin D. Cooper, Newman Yeilding, Yuhua Wang, Charles Pendley, Uma Prabhakar, Jackson Wong, Cuc Davis, Stephen Xu, Carrie Brodmerkel	2010	45
15	Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study Arthritis Research & Therapy ·Josef S Smolen, Jonathan Kay, Mittie K. Doyle, Robert Landewé, Eric L. Matteson, Norman Gaylis, J. Wollenhaupt, Frederick T. Murphy, Stephen Xu, Yiying Zhou, Elizabeth C. Hsia	2015	42
16	Safety and Efficacy of Subcutaneous Golimumab in Patients with Active Rheumatoid Arthritis despite Methotrexate Therapy: Final 5-year Results of the GO-FORWARD Trial The Journal of Rheumatology ·Edward Keystone, Mark C. Genovese, Stephen Hall, Sang‐Cheol Bae, Chenglong Han, Timothy Gathany, Stephen Xu, Yiying Zhou, Jocelyn H. Leu, Elizabeth C. Hsia	2015	37
17	Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial Trials ·Dafna D. Gladman, Philip J. Mease, Paul Bird, Enrique R. Soriano, Soumya D. Chakravarty, M. Shawi, Stephen Xu, Sean T. Quinn, Cinty Gong, Evan Leibowitz, Denis Poddubnyy, Lai‐Shan Tam, Philip Helliwell, Arthur Kavanaugh, Atul Deodhar, Mikkel Østergaard, Xenofon Baraliakos	2022	36
18	Efficacy and Safety of Subcutaneous Golimumab in Methotrexate‐Naive Patients With Rheumatoid Arthritis: Five‐Year Results of a Randomized Clinical Trial Arthritis Care & Research ·Paul Emery, Roy Fleischmann, Ingrid Strusberg, Patrick Durez, Peter Nash, Eric Amante, Melvin Churchill, Won Park, Bernardo A. Pons‐Estel, Chenglong Han, Timothy Gathany, Stephen Xu, Yiying Zhou, Jocelyn H. Leu, Elizabeth C. Hsia	2015	35
19	Golimumab, a Human Anti–Tumor Necrosis Factor Monoclonal Antibody, Injected Subcutaneously Every 4 Weeks in Patients With Active Rheumatoid Arthritis Who Had Never Taken Methotrexate: 1‐Year and 2‐Year Clinical, Radiologic, and Physical Function Findings of a Phase III, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Study Arthritis Care & Research ·Paul Emery, Roy Fleischmann, Mittie K. Doyle, Ingrid Strusberg, Patrick Durez, Peter Nash, Eric Amante, Melvin Churchill, Won Park, Bernardo A. Pons‐Estel, Weichun Xu, Stephen Xu, Wu Zhong, Elizabeth C. Hsia	2013	35
20	Associations between the genetic polymorphisms of MTHFR and outcomes of methotrexate treatment in rheumatoid arthritis. PubMed ·H. Xiao, Jing Xu, X. Zhou, Jim Stankovich, Faming Pan, Zhihui Zhang, Stephen Xu, (unknown), Changhai Ding	2010	34

About Stephen Xu

Stephen Xu is a scholar working on Rheumatology, Genetics, Hematology, Physiology and Immunology, having authored 63 papers that have together received 1.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (24 papers), Spondyloarthritis Studies and Treatments (23 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Systemic Lupus Erythematosus Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers) and Advanced Fluorescence Microscopy Techniques (2 papers). The work is most often cited by research in Rheumatology (1.2k citations), Hematology (333 citations), Immunology (448 citations), Dermatology (78 citations) and Genetics (74 citations). Stephen Xu has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Benjamin Hsu, Désirée van der Heijde, Jürgen Braun, Elizabeth C. Hsia, Robert D. Inman, Daniel Aletaha, Josef S Smolen, E. William St. Clair, Atul Deodhar and Yiying Zhou. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Arthritis Care & Research, Arthritis Research & Therapy and Rheumatology and Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Stephen Xu

Impact in

Papers in i

In The Last Decade

Stephen Xu

Peers

Countries citing papers authored by Stephen Xu

Fields of papers citing papers by Stephen Xu

All Works

About Stephen Xu

Explore authors with similar magnitude of impact

Papers in